Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab : the BEYOND study (GEMCAD 17-01) - Aparicio Urtasun, Jorge (Hospital Universitari i Politècnic La Fe (València)) ; Virgili Manrique, Anna Cristina (Institut d'Investigació Biomèdica Sant Pau) ; Capdevila, J. (IOB-Teknon) ; Muñoz Boza, F. (Hospital Universitari Sant Joan de Reus (Tarragona)) ; Galván, Patricia (Hospital Clínic i Provincial de Barcelona) ; Richart, P. (Hospital Universitari i Politècnic La Fe (València)) ; Oliveres, H. (Hospital Clínic i Provincial de Barcelona) ; Páez, David (Institut d'Investigació Biomèdica Sant Pau) ; Hernando Cubero, Jorge (Vall d'Hebron Institut d'Oncologia) ; Serrano, S. (Hospital Universitari Sant Joan de Reus (Tarragona)) ; Vera, R. (Complejo Hospitalario de Navarra) ; Hernandez-Yagüe, X. (ICO. Girona) ; Gallego, R.Á. (Medical Oncology Department. Hospital Madrid Norte San Chinarro-Centro Integral Oncologico Clara Campal) ; Riesco-Martinez, M.C. (Hospital Universitario) ; García de Albeniz, X. (RTI Health Solutions) ; Maurel, Joan (Hospital Clínic i Provincial de Barcelona)
 
Comments (0) | Reviews (0)
Start a discussion about any aspect of this document.

 Subscribe to this discussion. You will then receive all new comments by email.

Add comment


Once logged in, authorized users can also attach files.
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.
          You can use some HTML tags: <a href>, <strong>, <blockquote>, <br />, <p>, <em>, <ul>, <li>, <b>, <i>